GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » YoY EBITDA Growth

Anti-Microbialvior BioteQ Co (ROCO:6864) YoY EBITDA Growth : -17.49% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Anti-Microbialvior BioteQ Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -17.49%.

Anti-Microbialvior BioteQ Co's EBITDA per Share for the six months ended in Dec. 2024 was NT$-1.12.

Anti-Microbialvior BioteQ Co YoY EBITDA Growth Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co YoY EBITDA Growth Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial -46.56 21.76 -15.89 -45.90 -14.96

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.71 -77.53 -27.55 -10.76 -17.49

Anti-Microbialvior BioteQ Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Anti-Microbialvior BioteQ Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-2.006--1.745)/ | -1.745 |
=-14.96 %

Anti-Microbialvior BioteQ Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-1.115--0.949)/ | -0.949 |
=-17.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anti-Microbialvior BioteQ Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Anti-Microbialvior BioteQ Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » YoY EBITDA Growth
Comparable Companies
ROCO:6492 TPE:1733 TPE:6885 ROCO:7808 ROCO:4169 ROCO:4911 ROCO:6926 ROCO:6986 ROCO:6580 ROCO:6461 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741
Website
https://www.ams-bioteq.com
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co Headlines

No Headlines